Fluidnet is a medical device start-up that is developing a radically new platform targeting the $5B global infusion pump market. The Company is backed by leading venture capital firms, including Cardinal Partners, Rockport Venture Partners, Fidelity BioSciences, SCP Vitalife Partners, and Easterly Capital.
Fluidnet’s board and founding CEO determined the company needed a seasoned executive to raise additional funds and to manage the company as it approached commercialization.
Travis & Company met with board members, the founding CEO and key members of the executive team. As a result, we developed a deep understanding of the company and the priorities of the different stakeholders.
We conducted a national search, reporting regularly to a committee consisting of the board chairman, the company founder, and another board member. The search was completed on time with the hire of an outstanding executive.
The new CEO made an immediate impact. He refined the company’s strategic focus, rebuilt the management team, raised the company’s largest round of funding to date, and achieved key milestones.